Wadhwa P, Jain P, Rudrawar S, Jadhav HRA. Quinoline, Coumarin and Other Heterocyclic Analogs Based HIV-1 Integrase Inhibitors.
Curr Drug Discov Technol 2019;
15:2-19. [PMID:
28558629 DOI:
10.2174/1570163814666170531115452]
[Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2017] [Revised: 05/24/2017] [Accepted: 05/26/2017] [Indexed: 11/22/2022]
Abstract
Human Immunodeficiency Virus Type 1 Integrase or HIV-1 integrase (IN) is a 288 amino acid protein that incorporates the retrotranscribed viral DNA into the host chromosomal DNA. Over the past 30 years, large number of derivatives have been evaluated for their inhibitory potential against IN. There is vast literature available which need to be collated to help scientists plan the future drug design. This review discusses the reports of past 25 years on analogs of quinoline, coumarin and other related heterocycles, which exhibit low micromolar inhibitory potency against IN.
Collapse